Skip to content

Evaluation of a New Coating in Cement Less Femoral Stems

No Mid-term Advantage by Electrochemical Deposition of Hydroxyl-apatite in Cementless Femoral Stems. 5-year RSA and DXA Results From a Randomized Controlled Trial

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02321683
Enrollment
55
Registered
2014-12-22
Start date
2003-12-31
Completion date
2008-12-31
Last updated
2014-12-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hip Osteoarthritis

Brief summary

The purpose of this trial is to evaluate a new method of applying hydroxyapatite coatings on cement-less femoral stems.

Detailed description

60 patients eligible for total hip replacement will be randomized in to two groups, receiving either femoral stems with plasma sprayed hydroxyapatite coating or stems with electrochemically deposited hydroxyapatite. This patients will be followed for at least 5 years. The outcome is evaluated by comparing stability measured by RSA and periprosthetic bone remodeling measured by bone densitometry.

Interventions

DEVICETaperloc

Femoral stem with electrochemical deposition of hydroxyapatite

Sponsors

Zimmer Biomet
CollaboratorINDUSTRY
Lars Nordsletten
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* non-inflammatory hip arthritis, life expectancy of at least 10 years and hip anatomy allowing the use of standard implants

Exclusion criteria

* infection, revision surgery, severe morbidity and obvious bone loss

Design outcomes

Primary

MeasureTime frameDescription
Early and intermediate periprosthetic bone remodeling5 yearsBone densitometry measured by DXA
Early and intermediate femoral stem stability5 yearsRadiostereometric analysis of femoral stem movements relative to bone

Secondary

MeasureTime frameDescription
Clinical function5 yearsHip questionares, Harris Hip Score and Oxford Hip Score
Radiographic signs of loosening5 yearsConventional x-ray

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026